08 jun: Damark/vismand: Regeringen skal finde nye penge
10 jun: Overskud i APM´s containerforretning
08-06-2012 23:55:00

J&J to Record $600 Million Charge in 2Q

Relateret indhold

Johnson & Johnson (JNJ) said it plans to record a special charge of roughly $600 million in its second quarter to increase its accrual for potential legal settlements, as it has faced a series of lawsuits over accusations of bribery and improper drug-marketing practices.

The company said the settlement payments stem for a series of outstanding civil cases that involve its drugs Risperdal, Invega and Natrecor, as well as nursing-home pharmacy operator Omnicare Inc. (OCR).

The health-care products company has faced lawsuits related to alleged off-label promotion of its antipsychotic treatment Risperdal, which was once J&J's top-selling drug before generic copycats hit the market, as well as legal challenges over off-label promotion of another schizophrenia treatment, Invega, and the heart-failure drug Natrecor.

Furthermore, the federal government is suing J&J, accusing it of paying kickbacks to induce Omnicare to encourage use of Risperdal and other J&J drugs.

In addition, J&J has dealt with state lawsuits regarding its promotion of Risperdal, including an Arkansas case in which the company in April was ordered to pay $1.2 billion after a jury found that J&J's past marketing of the drug violated the state's consumer-protection laws. J&J previously was ordered to pay $327 million in a South Carolina case and $258 million in Louisiana. The company is appealing all three cases.

In January, J&J agreed to settle a Texas case for $158 million.

Meanwhile, the company agreed to pay an $85 million fine in a criminal case regarding off-label marketing of Natrecor. Parallel civil litigation still hasn't been settled.

The company in April said its first-quarter earnings rose on a foreign-exchange-related gain tied to an acquisition and lower expenses.

Shares closed Friday at $62.98 and were unchanged after hours. The stock is down 4% so far this year.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

(END) Dow Jones Newswires

June 08, 2012 17:55 ET (21:55 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

GE Wind solgte igen færre vindmøller i andet kvartal

21-07-2017 13:02:07
General Electric (GE) havde igen et fald i antallet af bestilte og afskibede vindmøller i andet kvartal i GE Wind-forretningen, der er en af Vestas' store konkurrenter.GE Winds ordreindgang faldt til 567 møller fra 637 i samme kvartal for et år siden, og der blev sendt 757 afsted til kunderne mod 856 i andet kvartal af 2016.Det var andet kvartal i træk med fald i ordrerne og tredje i træk med et l..

Aktier/middag: FLSmidth får stryg og tager bunden i C20

21-07-2017 11:42:46
FLSmidth er under pres på et positivt dansk aktiemarked, der fredag er præget af sommerferie med begrænset volumen og nyhedsstrøm.Den danske ingeniørkoncern er i fokus, da den finske rival Metso har offentliggjort et svagt regnskab for andet kvartal, hvor driftsoverskuddet på 59,8 mio. euro var et stykke fra det ventede plus på 78 mio. euro.Et positivt element var dog, at forventningerne til efter..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Tidligere børsdarling skuffer massivt i andet kvartal
2
Vestas henter amerikansk ordre på 200 MW - NY
3
Aktier/middag: FLSmidth får stryg og tager bunden i C20
4
Fredagens aktier: Mærsk, Novo og FLSmidth sendte C20 til tælling
5
Danske Bank/Jyske: Tror stadig på større overskud end banken selv

Relaterede aktiekurser

Johnson & Johnson 135,31 -0,9% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
21. juli 2017 22:39:38
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170720.2 - EUROWEB4 - 2017-07-21 22:39:38 - 2017-07-21 22:39:38 - 1 - Website: OKAY